Bruker Corporation (BRKR): A Bull Case Theory
We came across a bullish thesis on Bruker Corporation on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on BRKR.
Bruker Corp (BRKR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Montanaro Asset Management Charles Montanaro | 310,700 | $12,800,840 | -3% | 3.3% |
| 2. | Antipodes Partners Jacob Mitchell | 6,788 | $279,687 | +34% | 0.01% |
| 3. | Bayforest Capital Theodoros Tsagaris | 3,075 | $126,690 | +119% | 0.06% |
| 4. | Solstein Capital Nadine Terman And Jc Torres | 140 | $5,768 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.36 | 2,608 | $100,042.88 | 38,462,171 | 2025-06-06 | Filing | |
| $47.40 | 500 | $23,697.50 | 3,472 | 2025-03-10 | Filing | |
| $51.23 | 6,937 | $355,382.51 | 38,459,563 | 2025-02-18 | Filing | |
| $50.75 | 13,063 | $662,947.25 | 38,452,626 | 2025-02-18 | Filing | |
| $51.36 | 3,583 | $184,022.88 | 38,439,563 | 2024-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $57.82 | 3,350 | $193,682.60 | 80,904 | 2024-12-02 | Filing | |
| $63.14 | 4,684 | $295,747.76 | 30,963 | 2024-08-15 | Filing | |
| $89.61 | 1,228 | $110,041.08 | 23,147 | 2024-03-04 | Filing | |
| $90.10 | 13,772 | $1,240,857.20 | 24,375 | 2024-03-04 | Filing | |
| $84.48 | 1,500 | $126,720.00 | 32,859 | 2024-02-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,501,249 | $391,451,461 | 14.91% | |
| 2. | 2,058,535 | $84,825,225 | 0.01% | |
| 3. | 1,293,645 | $53,298,174 | 0.5% | |
| 4. | 899,042 | $37,040,525 | 0.01% | |
| 5. | 750,234 | $30,909,641 | 0.03% |
News See All
Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to Bruker Corporation's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment
In a statement, Bruker Corporation (NASDAQ:BRKR) said that revenues during the period were expected to settle at $795 million to $798 million, which suggests a flat performance from the same period last...
Bruker Acquires Majority Stake in RECIPE, Boosts Diagnostic and Drug Monitoring Capabilities
Bruker Corporation (NASDAQ:BRKR) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.
30 Stocks Expected To Beat the Market By 20 Percentage Points This Year
The US stock market has gone through a turbulent journey this year. Following a correction in March and a lull in April, the S&P 500 recovered its losses in May and June.
Bruker Corporation (BRKR) Fell Amid Cautious Outlook
Brown Brothers Harriman & Co., a global financial services firm, released its “The BBH Select Series – Mid Cap Fund” first quarter investor letter. A copy of the same can be downloaded here.
AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology
AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best Canadian stocks with huge upside potential.
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions
Bruker Corporation (NASDAQ:BRKR) announced the acquisition of Biocrates Life Sciences AG, a prominent Austrian company specialized in quantitative metabolomics.
Should You Invest in Bruker Corp (BRKR)?
RGA Investment Advisors, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
